Mereo BioPharma Group plc Skyrocketed
Mereo BioPharma Group plc (MREO:NASDAQ) jumped higher at $1.3, a gain of 62.5%. On Thu, Jun 16, 2022, MREO:NASDAQ touched a New 2-Week High of $0.8. The stock appeared on our News Catalysts scanner on Fri, Jun 17, 2022 at 04:13 PM in the 'PATNERSHIP' category. From Fri, Jun 03, 2022, the stock recorded 66.67% Up Days and 90.00% Green Days
About Mereo BioPharma Group plc (MREO:NASDAQ)
Mereo BioPharma Group PLC was incorporated and registered in England and Wales under the name Mereo BioPharma Group Limited on March 10, 2015. On June 3, 2016, the Company re-registered as a public company and changed its name to Mereo BioPharma Group PLC. The Company is a speciality biopharmaceutical company. The Company is principally engaged in the research and development of novel pharmaceuticals.
Top 10 Gainers:
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Revlon, Inc. (REV:NYSE), 91.28%
- Mereo BioPharma Group plc (MREO:NASDAQ), 62.5%
- SoundHound AI Inc. (SOUN:NASDAQ), 49.81%
- Swvl Holdings Corp (SWVL:NASDAQ), 35.29%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 31.87%
- Jupiter Wellness Inc. (JUPW:NASDAQ), 31.43%
- Satellogic Inc. (SATL:NASDAQ), 29.56%
- Electric Last Mile Solutions Inc. (ELMS:NASDAQ), 29.43%
- Sesen Bio, Inc. (SESN:NASDAQ), 29.21%